Novartis To Buy 85% Of Zhejiang Tianyuan For About CNY850 Million

By DJN on November 4, 2009 | Post a Comment
Source:

SHANGHAI -(Dow Jones)- Swiss pharmaceutical giant Novartis AG (NVS) said Wednesday it will buy an 85% stake in Zhejiang Tianyuan Bio-Pharmaceutical Co. for around CNY850 million ($125 million) as part of efforts to expand its presence in China's vaccine industry.

Privately owned Zhejiang Tianyuan, based in Zheijiang province, entered the Chinese vaccine industry in 1994 and has around 247 employees, according to the company's Web site.

The deal is subjected to Chinese regulatory approval.

-By Michelle Ng, Dow Jones Newswires; 86-21-6120-1200; michelle.ng@dowjones.com

(END) Dow Jones Newswires

11-04-09 0221ET



Post a comment

Comments Comments

Post Your Comment Post Your Comment

  or     to post comments


Featured Guide

Vault Guide to the Case Interview
Vault Guide to the Case Interview

US $29.95
Prepare for your case and consulting interview with the best-selling Vault Guide to the Case Interview. Packed with information you need to know to prepare for your case or consulting interview, this More info

Add     PDF download

Add     Printed book

View all guides